Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans

Background— In the general population, blacks experience higher mortality than their white peers, attributed in part to their lower socioeconomic status, reduced access to care, and possibly intrinsic biological factors. Patients with kidney disease are a notable exception, among whom blacks experience lower mortality. It is unclear if similar differences affecting outcomes exist in patients with no kidney disease but with equal or similar access to health care. Methods and Results— We compared all-cause mortality, incident coronary heart disease, and incident ischemic stroke using multivariable-adjusted Cox models in a nationwide cohort of 547 441 black and 2 525 525 white patients with baseline estimated glomerular filtration rate ≥60 mL·min−1·1.73 m−2 receiving care from the US Veterans Health Administration. In parallel analyses, we compared outcomes in black versus white individuals in the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. After multivariable adjustments in veterans, black race was associated with 24% lower all-cause mortality (adjusted hazard ratio, 0.76; 95% confidence interval, 0.75–0.77; P<0.001) and 37% lower incidence of coronary heart disease (adjusted hazard ratio, 0.63; 95% confidence interval, 0.62–0.65; P<0.001) but a similar incidence of ischemic stroke (adjusted hazard ratio, 0.99; 95% confidence interval, 0.97–1.01; P=0.3). Black race was associated with a 42% higher adjusted mortality among individuals with estimated glomerular filtration rate ≥60 mL·min−1·1.73 m−2 in NHANES (adjusted hazard ratio, 1.42; 95% confidence interval, 1.09–1.87). Conclusions— Black veterans with normal estimated glomerular filtration rate and equal access to healthcare have lower all-cause mortality and incidence of coronary heart disease and a similar incidence of ischemic stroke. These associations are in contrast to the higher mortality experienced by black individuals in the general US population.

[1]  Keith C. Norris,et al.  Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans". , 2016, Circulation.

[2]  I. Mozoș Mechanisms Linking Red Blood Cell Disorders and Cardiovascular Diseases , 2015, BioMed research international.

[3]  Nicholette D. Palmer,et al.  APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes , 2014, Kidney international.

[4]  W. Cushman,et al.  Association of Medical Treatment Nonadherence With All-Cause Mortality in Newly Treated Hypertensive US Veterans , 2014, Hypertension.

[5]  K. Kalantar-Zadeh,et al.  Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. , 2014, JAMA internal medicine.

[6]  R. Holman,et al.  Ethnicity and long‐term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83) , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[7]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[8]  Ishir Bhan,et al.  Vitamin D-binding protein and vitamin D status of black Americans and white Americans. , 2013, The New England journal of medicine.

[9]  M. Fornage,et al.  APOL1 variants associate with increased risk of CKD among African Americans. , 2013, Journal of the American Society of Nephrology : JASN.

[10]  K. Kalantar-Zadeh,et al.  Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  F. Recchia,et al.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. , 2013, American journal of physiology. Heart and circulatory physiology.

[12]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[13]  B. Freedman,et al.  Effect of race and genetics on vitamin D metabolism, bone and vascular health , 2012, Nature Reviews Nephrology.

[14]  Keith C. Norris,et al.  Allostatic load burden and racial disparities in mortality. , 2012, Journal of the National Medical Association.

[15]  R. Townsend,et al.  Hypertension in the US Black Population: Risk Factors, Complications, and Potential Impact of Central Aortic Pressure on Effective Treatment , 2012, Cardiovascular Drugs and Therapy.

[16]  G. Genovese,et al.  Population-based risk assessment of APOL1 on renal disease. , 2011, Journal of the American Society of Nephrology : JASN.

[17]  C. Moy,et al.  Disparities in stroke incidence contributing to disparities in stroke mortality , 2011, Annals of neurology.

[18]  C. Winkler,et al.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. , 2010, Journal of the American Society of Nephrology : JASN.

[19]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[20]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[21]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[22]  Donald W. Bowden,et al.  Association of Trypanolytic ApoL 1 Variants with Kidney Disease in African Americans , 2010 .

[23]  E. Tarlov,et al.  Use of Medicare and DOD data for improving VA race data quality. , 2010, Journal of rehabilitation research and development.

[24]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[25]  T. Davis Ethnic diversity in Type 2 diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[26]  L. Agodoa,et al.  Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[27]  K. Kalantar-Zadeh,et al.  Racial and survival paradoxes in chronic kidney disease , 2007, Nature Clinical Practice Nephrology.

[28]  C. Berg,et al.  The Black-White disparity in pregnancy-related mortality from 5 conditions: differences in prevalence and case-fatality rates. , 2007, American journal of public health.

[29]  F. Duelm,et al.  Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. military , 2007 .

[30]  S. Cochran,et al.  Race, race-based discrimination, and health outcomes among African Americans. , 2007, Annual review of psychology.

[31]  D. Hospenthal,et al.  Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. , 2006, Military medicine.

[32]  Timothy J Wilt,et al.  Transition to the new race/ethnicity data collection standards in the Department of Veterans Affairs , 2006, Population health metrics.

[33]  J. Pankow,et al.  Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network. , 2006, The American journal of cardiology.

[34]  C. Maynard,et al.  Accuracy and completeness of mortality data in the Department of Veterans Affairs , 2006, Population health metrics.

[35]  Avis J. Thomas,et al.  Race/ethnicity, income, major risk factors, and cardiovascular disease mortality. , 2005, American journal of public health.

[36]  M. Feinleib National Center for Health Statistics (NCHS) , 2005 .

[37]  R. Detrano,et al.  Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[38]  Rosalind Wright,et al.  Population disparities in asthma. , 2005, Annual review of public health.

[39]  Anita Deswal,et al.  Impact of race on health care utilization and outcomes in veterans with congestive heart failure. , 2004, Journal of the American College of Cardiology.

[40]  P. O'Malley,et al.  The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. , 2003, Journal of the American College of Cardiology.

[41]  Jennifer Y. Liu,et al.  Ethnic disparities in diabetic complications in an insured population. , 2002, JAMA.

[42]  D. Washington,et al.  Racial variations in Department of Veterans Affairs ambulatory care use and unmet health care needs. , 2002, Military medicine.

[43]  V. Pavlik,et al.  Characteristics of patients with uncontrolled hypertension in the United States. , 2001, The New England journal of medicine.

[44]  J. W. Reed,et al.  Coronary heart disease in African Americans. , 2001, Heart disease.

[45]  A. Jha,et al.  Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. , 2001, JAMA.

[46]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[47]  G. Samsa,et al.  Race, treatment, and survival among colorectal carcinoma patients in an equal‐access medical system , 1998, Cancer.

[48]  J. Neaton,et al.  Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial , 1998 .

[49]  C W Maklan,et al.  Department of Veterans Affairs. , 1998, Medical care.

[50]  R. Gillum,et al.  Coronary Heart Disease Incidence and Survival in African-American Women and Men: The NHANES I Epidemiologic Follow-up Study , 1997, Annals of Internal Medicine.

[51]  J Bound,et al.  Excess mortality among blacks and whites in the United States. , 1996, The New England journal of medicine.

[52]  R. Weinstein,et al.  Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. , 1995, Archives of internal medicine.

[53]  Thomas E. Moritz,et al.  Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. , 1993, Archives of internal medicine.

[54]  S. Jablon,et al.  Effects of selection on mortality. , 1974, Statistical bulletin.